Collectively, the presence of malignant transformed cells with lost polarity increases serum Fuc-Hp levels via both increased fucosylation status and increased secretion of fucosylated proteins into the serum, which may explain why high Fuc-Hp levels after DAA treatment were a risk factor for HCC development. The gene discussed is HP; the disease is hepatocellular carcinoma.